Transdermal Drug Delivery System: formulation, development and evaluation-An overview

Authors

  • Ritesh Suresh Bathe Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola-413307, Solapur, Maharashtra
  • Reni Kapoor Department of Pharmaceutics, Akal College of Pharmacy, Mastuana sahib Sangrur,Punjab

DOI:

https://doi.org/10.7439/ijbar.v6i1.1556

Abstract

In a transdermal drug delivery system the drug is applied in a relatively high dosage to the inside of a patch, which is worn on the skin for an extended period of time. Through a diffusion process, the drug enters the bloodstream directly through the skin. Since there is high concentration on the patch and low concentration in the blood, the drug will keep diffusing into the blood for a long period of time, maintaining the constant concentration of drug in the blood flow. Transdermal drug delivery system was introduced to overcome the difficulties of drug delivery through oral route.The conventional oral dosage forms have significant setbacks of poor bioavailability due to hepatic first pass metabolism. To improve characters of transdermal drug delivery system (TDDS) was emerged, which will improve the therapeutic efficacy and safety of drugs by specific sites within the body, thereby reducing both the size and number of doses. This review article describes the methods of preparation of different types of transdermal patches such as matrix patches, reservoir type, membrane matrix, drug-in-adhesive patches and micro reservoir patches.

Downloads

Download data is not yet available.

References

Vyas S.P. And Khar R.K. Controlled Drug Delivery: Concepts and Advances, first edition, Vallabh Prakashan, 2002, pp 411-447.

Keleb E, Sharma RK, Mosa EB, Aljahwi AZ. Transdermal Drug Delivery System- Design and Evaluation. International Journal of Advances in Pharmaceutical Sciences 2010; 1: 201-211.

Tortara GS, Grabowski SK. Principles of Anatomy and Physiology, nineth edition, 2000, pp 140-194.

Schofield OMV, Rees JL. Skin disease, In Hunter J editor, Devidsins principle and practices of medicine, 19th edition, Churchill Livingstone, , 2002, pp 1049-1055.

Images [Internate] URL : http/Google.com/images.

Chad RW. Development and Selection of Components for Transdermal Drug Delivery Systems, [ Internate].

Touitou E , Junginger H, Weiner N D, Nagai T , Mezei M . liposomes as a carrier fortopical and transdermal drug delivery. Journal of pharmaceutical science 1994; 83:1 1189-1203.

WissingSA,Muller R H. The influence of solid lipid nanoparticles on skin hydration & viscoelasticity -In vivo study. European Journal of Pharmaceutics and Biopharmaceutics. 2003; 56: 67-72.

Guy R H, KaliaYN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis : electro repulsion and el ectroosmosis. J control release. 2000; 64:129 -132 .

Mitragotri S, Blankschtein D , Langer R. Ultrasound mediated transdermal protein delivery. Science. 1995; 269: 850 -853 .

Lee W R, Shen SC , Lai HH, Hu CH, Fang J Y. Transdermal drug delivery enhanced and controlled by erbium:YAG laser. J controlled release. 2001; 75:155-166 .

Treffel P, Panisset FF, Humbert P , Remoussenard O, Bechtel Y, Agache P. Effect of pressure on in vitro percutaneous absorption of caffeiene.Acta.Derm.Venereo . 1993; 73: 200 -202.

B rown MB, Traynor MJ, Martin GP, Akomeah FK. Drug Delivery Systems: Skin Perturbation Devices. Methods in Molecular Biology. 2008; 437 : 119 -139.

Mitragotri S, Blankschtein D, Langer R. Transdermal drug delivery using low-frequency sonophoresis: Pharm. Res. 1996 oct-dec; 13(3): 411-420.

Aulton.M.E, Pharmaceutics; The science of dosage form design. 2nded, Harcourt publishers; Churchill Livingston; 2002. p. 398-411.

Ansel.H.C, Loyd.A.V, Popovich.N.G, Pharmaceutical dosage forms and drug delivery systems: transdermal drug delivery system. 7th ed. Lippincott Williams and Willkins publication. p. 298-313.

Chein YW. Transdermal Drug Delivery, In: Swarbick J. Editor, Novel Drug Delivery Systems, second edition, New York: Marcel Dekker, 2005, 50, pp 301

Zhou Y, Wu XY. Fine element analysis of diffusional drug release from complex matrix system, J control Rel 1997; 49: 277

Chad RW. Development and Selection of Components for Transdermal Drug Delivery Systems, [ Internate].

Mehetra R. Topical and transdermal drug delivery : What a pharmacist needs to know, InetCE221-146-04-054-H01. [Internate]

Levin G, Kornfeld J, Patel Y R, Damon S. Transdermal Delivery Success Through A Deep Understanding Of The Skin Corium. [Internet]. 2007 Available from: URL: http://www.ondrugdelivery.com

Shah S. Transdermal Drug Delivery Technology Revisited Recent advances: Pharm info net. 2008 march; 6(5): 98-106.

Joseph S D. Transdermal Patches: An Innovative Drug Delivery System That Has Raised Serious Safety Concerns. News Inferno. [internet]. 2006 [cited 2011feb 22]. Availaible from: URL: http://www.newsinferno.com.

Morrow T. Transdermal Patches Are More Than Skin Deep. Managed care. [Internet] 2004 [cited 2011 feb4]. Available online: URlhttp://www.managedcaremag.com.

Aggarwal S, Priya M. Permeation Studies of Atenolol and Metoprolol Tartrate from Three Different Matrices for Transdermal Delivery: Indian. J. Pharm. Sci. 2007 June; 69(4): 535?539.

ChandrashekhraN S.Current Status and Future Prospects in Transdermal Drug Delivery. Pharmainfo.net. 2008.

Hemangi .J,JitendraS, Desai .B, Keyur.D. Design and evaluation of Amlodipine besilate transdermal patches containing film former: ijprd. 2009 sept; 7(001): 1- 12.

Downloads

Published

2015-01-30

Issue

Section

Review Article

How to Cite

Transdermal Drug Delivery System: formulation, development and evaluation-An overview. (2015). International Journal of Biomedical and Advance Research, 6(1), 1-10. https://doi.org/10.7439/ijbar.v6i1.1556